AUTHOR AND EDITOR INFORMATION

Section 1 of 12  

• Authors and Editors
• Introduction
• Indications
• Relevant Anatomy
• Contraindications
• Workup
• Treatment
• Complications
• Outcome and Prognosis
• Future and Controversies
• Multimedia
• References

INTRODUCTION

Section 2 of 12  

• Authors and Editors
• Introduction
• Indications
• Relevant Anatomy
• Contraindications
• Workup
• Treatment
• Complications
• Outcome and Prognosis
• Future and Controversies
• Multimedia
• References

Tetralogy of Fallot (TOF) is one of the most common congenital heart disorders (CHDs). TOF is classified as a cyanotic heart disorder because the condition results in an inadequate flow of oxygenated blood to the systemic circulation. Patients with TOF initially present with cyanosis shortly after birth, thereby attracting early medical attention.

The 4 features typical of TOF include right ventricular outflow tract obstruction (RVOTO) (infundibular stenosis), ventricular septal defect (VSD), aorta dextroposition, and right ventricular hypertrophy. Occasionally, a few children also have an atrial septal defect, which makes up the pentad of Fallot. The basic pathology of tetralogy is due to the underdevelopment of the right ventricular infundibulum, which results in an anterior-leftward malalignment of the infundibular septum. This malalignment determines the degree of RVOTO.

The clinical features of TOF are generally typical, and a preliminary clinical diagnosis can almost always be made. Since most infants with this disorder require surgery, it is fortunate that the availability of cardiopulmonary bypass (CPB), cardioplegia, and surgical techniques is now well established. Most surgical series report excellent clinical results with low morbidity and mortality rates.

History of the Procedure

Louis Arthur Fallot, after whom the name tetralogy of Fallot is derived, was not the first person to recognize the condition. Stensen first described TOF in 1672; however, it was Fallot who first accurately described the clinical and complete pathologic features of the defects.

Although the disorder was clinically diagnosed much earlier, no treatment was available until the 1940s. Cardiologist Helen Taussig recognized that cyanosis progressed and inevitably led to death in infants with TOF. She postulated that the cyanosis was due to inadequate pulmonary blood flow. Her collaboration with Alfred Blalock led to the first type of palliation for these infants. In 1944, Blalock operated on an infant with TOF and created the first Blalock-Taussig shunt between the subclavian artery and the pulmonary artery.

This pioneering surgical technique opened a new era in neonatal cardiac surgery. This was followed by development of the Potts shunt (from the descending aorta to the left pulmonary artery), the Glenn shunt (from the superior vena cava to the right pulmonary artery), and the Waterston shunt (from the ascending aorta to the right pulmonary artery).

Scott performed the first open correction in 1954. Less than half a year later, Lillehei performed the first successful open repair for TOF using controlled cross circulation, with another patient serving as oxygenator and blood reservoir. The following year, with the advent of CPB by Gibbons, another historic era of cardiac surgery was established. Since then, numerous advances in surgical technique and myocardial preservation have evolved in the treatment of TOF.

Frequency

TOF occurs in 3-6 infants for every 10,000 births and is the most common cause of cyanotic CHD. The disorder is observed in other mammals, including horses and rats. TOF accounts for a third of all CHD in patients younger than 15 years. In most cases, TOF is sporadic and nonfamilial. The incidence in siblings of affected parents is 1-5%, and it occurs more commonly in males than in females. The disorder is associated with extracardiac anomalies such as cleft lip and palate, hypospadias, and skeletal and craniofacial abnormalities.

Etiology

The causes of most CHDs are unknown, although genetic studies suggest a multifactorial etiology. Prenatal factors associated with a higher incidence of TOF include maternal rubella (or other viral illnesses) during pregnancy, poor prenatal nutrition, maternal alcohol use, maternal age older than 40 years, and diabetes. Children with Down syndrome have a higher incidence of TOF.

• Natural history
  • Early surgery is not indicated for all infants with TOF, although, without surgery, the natural progression of the disorder indicates a poor prognosis. The progression of the disorder depends on the severity of the RVOTO.
  • Without surgery, mortality rates gradually increase, ranging from 30% at age 2 years to 50% by age 6 years. The mortality rate is highest in the first year and then remains constant until the second decade. No more than 20% of patients can be expected to reach the age of 10 years, and fewer than 5-10% of patients are alive by the end of their second decade. Most individuals who survive to age 30 years develop congestive heart failure, although individuals whose shunts produce minimal hemodynamic compromise have been noted, albeit rarely, and these individuals achieve a normal life span. For more information on heart failure, see the Medscape Resource Center Heart Failure.
  • As might be expected, individuals with TOF and pulmonary atresia have the worst prognoses, and only 50% survive to age 1 year and 8% to age 10 years.
  • If left untreated, patients with TOF face additional risks that include paradoxical emboli leading to stroke, pulmonary embolus, and subacute bacterial endocarditis. For more information on stroke, see the Medscape Resource Center Stroke/Cerebrovascular Disease.

Pathophysiology

The hemodynamics of TOF depend on the degree of RVOTO. The VSD is usually nonrestrictive, and the right and left ventricular pressures are equalized. If the obstruction is severe, the intracardiac shunt is from right to left, and pulmonary blood flow may be markedly diminished. In this instance, blood flow may depend on the patent ductus arteriosus or bronchial collaterals.

Clinical

The clinical features are directly related to the severity of the anatomic defects. Most infants with TOF have difficulty with feeding, and failure to thrive is commonly observed. Infants with pulmonary atresia may become profoundly cyanotic as the ductus arteriosus closes unless bronchopulmonary collaterals are present. Occasionally, some children have just enough pulmonary blood flow and do not appear cyanotic; these individuals remain asymptomatic until they outgrow their pulmonary blood supply.

At birth, some infants with TOF do not show signs of cyanosis, but they may later develop episodes of bluish pale skin during crying or feeding (ie, Tet spells). A characteristic fashion in which older children with TOF increase pulmonary blood flow is to squat. Squatting is of diagnostic significance and is highly typical of infants with TOF. Squatting increases peripheral vascular resistance and thus decreases the magnitude of the right-to-left shunt across the VSD. Exertional dyspnea usually worsens with age. Occasionally, hemoptysis due to rupture of the bronchial collaterals may result in the older child.

The following factors can worsen cyanosis in infants with TOF:

• Acidosis
• Stress
• Infection
• Posture
• Exercise
• Beta-adrenergic agonists
• Dehydration
• Closure of the ductus

The predominant shunt is from right to left with flow across the VSD into the left ventricle, which produces cyanosis and an elevated hematocrit value. When the pulmonary stenosis is mild, bidirectional shunting may occur. In some patients, the infundibular stenosis is minimal, and the predominant shunt is from left to right, producing what is called a pink tetralogy. Although such patients may not appear cyanotic, they often have oxygen desaturation in the systemic circulation.

• Physical examination
• • Most infants are smaller than expected for age. Cyanosis of the lips and nail bed is usually pronounced at birth; after age 3-6 months, the fingers and toes show clubbing.
  • A thrill is usually present anteriorly along the left sternal border. A harsh systolic ejection murmur is heard over the pulmonic area and the left sternal border. When the right ventricular outflow obstruction (eg, from pulmonary atresia) is moderate, the murmur may be inaudible. The S₂ is usually single. During cyanotic episodes, murmurs may disappear, which is suggestive of lessened right ventricular outflow to the pulmonary arteries. In individuals with aortopulmonary collaterals, continuous murmurs may be auscultated.

INDICATIONS

Section 3 of 12  

• Authors and Editors
• Introduction
• Indications
• Relevant Anatomy
• Contraindications
• Workup
• Treatment
• Complications
• Outcome and Prognosis
• Future and Controversies
• Multimedia
• References

Since tetralogy of Fallot (TOF) is a progressive disorder, most infants require some type of surgical procedure. The timing of complete surgical repair is dependent on numerous variables, including symptoms and any associated lesions (eg, multiple ventricular septal defect [VSD], pulmonary atresia).

Today, the trend is to perform a complete surgical procedure (often electively) before the age of 1 year and preferably by the age of 2 years.

Most surgeons now recommend the primary procedure, and current results are excellent. Infants with cyanosis are stabilized by administering prostaglandins (to maintain the ductus in an open state). The use of prostaglandins has significantly decreased the need to perform urgent surgery. Instead of performing systemic-to-pulmonary artery shunts on critically ill cyanotic-hypoxic infants, surgeons now have the luxury of having extra time to assess the patient's anatomy and to perform the primary procedure.

Primary repair avoids prolonged right ventricular outflow obstruction and the subsequent right ventricular hypertrophy, prolonged cyanosis, and postnatal angiogenesis.

RELEVANT ANATOMY

Section 4 of 12  

• Authors and Editors
• Introduction
• Indications
• Relevant Anatomy
• Contraindications
• Workup
• Treatment
• Complications
• Outcome and Prognosis
• Future and Controversies
• Multimedia
• References

Patients with tetralogy of Fallot (TOF) can present with a broad range of anatomic deformities. Fallot initially described 4 major defects consisting of (1) pulmonary artery stenosis, (2) ventricular septal defect (VSD), (3) deviation of the aortic origin to the right, and (4) right ventricular hypertrophy. Today, however, the most important features of TOF are recognized as (1) the right ventricular outflow tract obstruction (RVOTO), which is nearly always infundibular and/or valvular, and (2) an unrestricted VSD associated with malalignment of the conal septum.

Right ventricle outflow tract obstruction

Clinically, most patients with TOF have an increased resistance to right ventricle emptying because of the pulmonary outflow tract obstruction. The anterior displacement and rotation of the infundibular septum causes right ventricular obstruction of variable degree and location. The obstruction may be adjacent to the pulmonary valve, causing additional obstruction.

Pulmonary arteries

The pulmonary arteries can vary in size and distribution, and they may be atretic or hypoplastic. Rarely, the left pulmonary artery is absent. In some individuals, a varying degree of stenosis of the peripheral pulmonary arteries occurs, which further restricts pulmonary blood flow.

Pulmonary atresia results in no communication between the right ventricle and the main pulmonary artery; in this case, pulmonary blood flow is maintained by either the ductus or collateral circulation from the bronchial vessels. With minimal RVOTO, pulmonary vascular disease may develop secondary to excessive pulmonary blood flow from the large left-to-right shunt or large aortopulmonary collaterals. In up to 75% of children with TOF, some degree of pulmonary valve stenosis may occur. Stenosis is usually due to leaflet tethering rather than commissural fusion. The pulmonary annulus is narrowed in virtually every case.

Aorta

True dextroposition and abnormal rotation of the aortic root result in aortic overriding (ie, an aorta that, to varying degrees, originates from the right ventricle). In some cases, more than 50% of the aorta may thus originate from the right ventricle. A right aortic arch may occur, which may lead to an abnormal origin of the arch vessels.

Associated anomalies

Associated defects are also common. The coexistence of an atrial septal defect (ASD) occurs often enough to prompt its inclusion in a so-called pentalogy of Fallot. Other possible defects include patent ductus arteriosus, atrioventricular septal defects, muscular VSD, anomalous pulmonary venous return, anomalous coronary arteries, absent pulmonary valve, aorticopulmonary window, and aortic incompetence.

The coronary anatomy may also be abnormal. Among these abnormalities is the origin of the left anterior descending (LAD) coronary artery from the proximal right coronary artery, which crosses the right ventricular outflow at variable distances from the pulmonary valve annulus. The anomalous LAD coronary artery is observed in 9% of TOF cases, and this abnormality makes placement of a patch across the pulmonary annulus risky, possibly requiring an external conduit. During the VSD repair, the anomalous LAD coronary artery is prone to injury. Occasionally, all coronary arteries arise from a single left main coronary ostium.

CONTRAINDICATIONS

Section 5 of 12  

• Authors and Editors
• Introduction
• Indications
• Relevant Anatomy
• Contraindications
• Workup
• Treatment
• Complications
• Outcome and Prognosis
• Future and Controversies
• Multimedia
• References

Contraindications to primary repair in tetralogy of Fallot (TOF) include the following:

• The presence of an anomalous coronary artery
• Very low birth weight
• Small pulmonary arteries
• Multiple VSDs
• Multiple coexisting intracardiac malformations

WORKUP

Section 6 of 12  

• Authors and Editors
• Introduction
• Indications
• Relevant Anatomy
• Contraindications
• Workup
• Treatment
• Complications
• Outcome and Prognosis
• Future and Controversies
• Multimedia
• References

Lab Studies

Hemoglobin and hematocrit values are usually elevated in proportion to the degree of cyanosis. The oxygen saturation in the systemic arterial blood typically varies from 65-70%. All patients with TOF who experience significant cyanosis have a tendency to bleed because of decreased clotting factors and low platelet count. The usual findings are diminished coagulation factors. The total fibrinogen levels are also diminished and are associated with prolonged prothrombin and coagulation times.

Imaging Studies

• Radiography
• • Initially, chest radiographs may not reveal any abnormality; however, diminished vascularity in the lungs and diminished prominence of the pulmonary arteries gradually become apparent.
  • The hallmark of TOF is the classic boot-shaped heart (coeur en sabot).
• Echocardiography
• • Today, ductus arteriosus, muscular VSD, or ASD are accurately diagnosed with color-flow Doppler echocardiography (ECG). The coronary anatomy can be revealed with some degree of accuracy, and valvar alterations can be detected with ease. In many institutions, echocardiography is the only diagnostic study used before surgery.
  • The use of ECG may be limited if multiple VSDs or coronary artery anomalies are present or if the distal pulmonary artery cannot be visualized adequately.
• Magnetic resonance imaging
• • Magnetic resonance imaging (MRI) provides good delineation of the aorta, right ventricular outflow tract, VSDs, right ventricular hypertrophy, and the pulmonary artery and its branches.
  • MRI can be used to measure intracardiac pressures, gradients, and blood flows.
  • Drawbacks to MRI include the need for prolonged imaging times and the requirement for sedation in small children to prevent motion artifacts. Additionally, sick infants cannot be observed when enclosed in an MRI tunnel.

Other Tests

• Electrocardiography
• • Right axis deviation with right ventricular enlargement may be seen.
  • If right ventricular hypertrophy is absent on ECG, the diagnosis of TOF should be suspected.

Diagnostic Procedures

• Cardiac catheterization
• • Cardiac catheterization provides angiographic visualization of ventricular and pulmonary artery size. Catheterization also helps obtain pressure and oxygen saturation measurements in different chambers and identifies any possible shunts. In the presence of preexisting shunts, angiograms should be obtained before complete surgical repair.
  • Angiograms help identify coronary artery anomalies; however, catheterization is not mandatory in all patients. Cardiac catheterization is extremely useful if the anatomy cannot be completely defined by ECG, if disease in the pulmonary arteries is a concern, or if pulmonary vascular hypertension is possible.

TREATMENT

Section 7 of 12  

• Authors and Editors
• Introduction
• Indications
• Relevant Anatomy
• Contraindications
• Workup
• Treatment
• Complications
• Outcome and Prognosis
• Future and Controversies
• Multimedia
• References

Medical therapy

Surgery is the definitive treatment for the cyanotic patient with tetralogy of Fallot (TOF). The primary role of medical therapy is in preparation for surgery. Most infants have adequate saturations and usually undergo elective repair. In infants with acute cyanotic episodes, placing them in a knee-chest position may prove helpful in addition to administering oxygen and intravenous morphine. In severe episodes, intravenous propranolol (Inderal) may be administered, which relaxes the infundibular muscle spasm causing RVOTO. Progressive hypoxemia and the occurrence of cyanotic spells are indications for early surgery. Asymptomatic infants need no special medical treatment.

Surgical therapy

Factors that increase the risk for early repair of TOF include the following:

• Low birth weight
• Pulmonary artery atresia
• Major associated anomalies
• Multiple previous surgeries
• Absent pulmonary valve syndrome
• Young age
• Old age
• Severe annular hypoplasia
• Small pulmonary arteries
• High peak right ventricular–to–left ventricular pressure ratio
• Multiple VSDs
• Coexisting cardiac anomalies

Palliative procedures

The goals of palliation are to increase pulmonary blood flow independent of ductal patency and to allow pulmonary artery growth and even total correction. Occasionally, an infant with pulmonary atresia or an anomalous LAD coronary artery that crosses the right ventricular outflow tract may not be a surgical candidate for establishing transannular right ventricle–to–pulmonary artery continuity and may require placement of a conduit.

Although artificial conduits can be used, infants with extremely small pulmonary arteries may not tolerate total correction in infancy. These infants may require palliation instead of corrective surgery. Various types of palliative procedures have been developed, but the current procedure of choice is the Blalock-Taussig shunt.

The Potts shunts has been abandoned because of a tendency toward increased pulmonary blood flow and increasing difficulty with takedown at the time of corrective surgery. The Waterston shunt is sometimes used, but it also increases pulmonary artery blood flow. This shunt is more related to pulmonary artery stenosis, which generally requires reconstruction. The Glenn shunt is no longer used because of difficulty in performing a subsequent definitive repair.

Given the problems associated with the aforementioned shunts, placement of the modified Blalock-Taussig shunt (using a Gore-Tex graft between the subclavian artery and pulmonary artery) is the procedure of choice. Advantages of the modified Blalock-Taussig shunt include (1) preservation of the subclavian artery, (2) suitability for use on either side, (3) good relief of cyanosis, (4) easier control and closure at time of primary repair, (5) excellent patency rate, and (6) decreased incidence of iatrogenic pulmonary/systemic artery trauma.

The mortality rate is reportedly less than 1% when placing this shunt. However, the Blalock-Taussig shunt elicits a few complications, including hypoplasia of the arm, digital gangrene, phrenic nerve injury, and pulmonary artery stenosis.

The longevity of palliation after shunt placement varies according to the patient's age at the time of surgery and the type of shunt.

Other forms of palliation that are rarely used today include patching of the right ventricular outflow tract without cardiopulmonary bypass (CPB). This procedure can cause destruction of the pulmonary valve and significant intrapericardial adhesions, and the increased pulmonary artery blood flow can result in congestive heart failure; therefore, its role is limited to treatment of infants with TOF complicated by pulmonary atresia and/or hypoplasia of the pulmonary artery.

In very ill neonates with multiple medical problems, balloon pulmonary valvulotomy has been shown to increase oxygen saturation, thus obviating the need for emergency palliative surgery. However, perforation of the pulmonary artery is a risk with this procedure in neonates.

Corrective surgery

Primary correction is the ideal operation for treatment of TOF and is usually performed under CPB. The aims of the surgery are to close the VSD, to resect the area of infundibular stenosis, and to relieve the RVOTO. Before CPB is initiated, previously placed systemic-to-pulmonary artery shunts are isolated and taken down. Patients then undergo CPB. Associated anomalies, such as ASD or patent foramen ovale, are closed.

Postoperative details

All infants undergoing open-heart procedures are sent to the pediatric intensive care unit. Hemodynamic parameters must be followed postoperatively. All infants initially remain intubated on a ventilator until cardiac and respiratory status stabilize. To maintain systemic peripheral perfusion, adequate cardiac output and atrial pacing may be required. Patients should be weighed daily to follow volume status. Patients with heart block should have temporary atrioventricular pacing. If intrinsic conduction has not returned in 5-6 days, the patient probably needs a permanent pacemaker.

Results

The outcome of surgical repair is excellent with minimal morbidity and mortality. To date, no difference in operative mortality rates has been noted between transventricular and transatrial approaches.

The occasional patient has an elevated right ventricle–to–left ventricle pressure ratio. This may be due to a number of causes including a residual VSD, pulmonary artery stenosis, and pulmonary artery and valve atresia. These patients tend to do poor and echocardiography (ECHO) is warranted to find the cause. Surgical revision may be required to correct the etiology of the high RV pressures.

With improved techniques, excellent results with early 1-stage repair in infants have been reported. Overall, the mortality rate in most series is 1-5% when the repair is performed primarily or after a systemic-to-pulmonary artery shunt. Similarly, the mortality rate of infants undergoing palliative shunt placement is low (0.5-3%). The survival rate at 20 years is approximately 90-95%.

Improved techniques of myocardial protection with hypothermia, cardioplegia, and even total circulatory arrest are providing excellent results by enabling more precise anatomic repairs in younger infants. Nevertheless, infants receiving complete correction before age 1 year have an increased risk compared with patients older than 1 year.

Revision/reoperation

The literature suggests that approximately 5% of individuals will need a revision/reoperation at some point. Indications for early reoperation include a residual VSD or a residual RVOTO.

Residual VSDs are poorly tolerated in patients with TOF because these individuals cannot tolerate an acutely imposed volume overload. Small, residual VSDs are common after TOF repair and are usually clinically insignificant. A residual VSD with a 2:1 shunt or an RVOTO of greater than 60 mm Hg is an urgent indication for reoperation. Surgery can be performed with low risk and can result in dramatic improvements. Occasionally, pulmonary valve insufficiency may increase and may be associated with right ventricular failure. Recurrent RVOTO may be due to muscular fibrosis or hypertrophy. This problem is generally treated with a pulmonary valve replacement. Porcine valves are preferred over mechanical valves because they have less tendency to thrombose.

COMPLICATIONS

Section 8 of 12  

• Authors and Editors
• Introduction
• Indications
• Relevant Anatomy
• Contraindications
• Workup
• Treatment
• Complications
• Outcome and Prognosis
• Future and Controversies
• Multimedia
• References

Early postoperative complications include the creation of heart block and residual ventricular septal defects (VSDs). Ventricular arrhythmias are more common and are reportedly the most frequent cause of late postoperative death. Sudden death from ventricular arrhythmias has been reported in 0.5% of individuals within 10 years of repair. The arrhythmias are thought to occur in fewer than 1% of patients having an early operation. As with most heart surgery, the risk of endocarditis is lifelong, but the risk is much less than in a patient with an uncorrected tetralogy of Fallot.

OUTCOME AND PROGNOSIS

Section 9 of 12  

• Authors and Editors
• Introduction
• Indications
• Relevant Anatomy
• Contraindications
• Workup
• Treatment
• Complications
• Outcome and Prognosis
• Future and Controversies
• Multimedia
• References

In the present era of cardiac surgery, children with simple forms of tetralogy of Fallot (TOF) enjoy good long-term survival with an excellent quality of life. Late outcome data suggest that most survivors are in New York Heart Association classification I, although maximal exercise capability is reduced in some. Sudden death from ventricular arrhythmias has been reported in 1-5% of patients at a later stage in life, and the cause remains unknown. The surgical procedures are still palliative, and continued cardiac monitoring into adult life is necessary.

FUTURE AND CONTROVERSIES

Section 10 of 12  

• Authors and Editors
• Introduction
• Indications
• Relevant Anatomy
• Contraindications
• Workup
• Treatment
• Complications
• Outcome and Prognosis
• Future and Controversies
• Multimedia
• References

Today, some tetralogy of Fallot patients have survived for more than 15-20 years after their first operation. The major problem encountered by these individuals is the development of pulmonary valvular regurgitation. It appears that a number of these individuals require pulmonary valve replacement. Most individuals receive a pericardial homograft and only time will tell how long these valves will last.

MULTIMEDIA

Section 11 of 12  

• Authors and Editors
• Introduction
• Indications
• Relevant Anatomy
• Contraindications
• Workup
• Treatment
• Complications
• Outcome and Prognosis
• Future and Controversies
• Multimedia
• References

Media file 1:  This image shows completed blocking with a Taussig shunt.
	View Full Size Image
Media type:  Photo

Media file 2:  An opening in the right ventricle exposes ventricular septal defect.
	View Full Size Image
Media type:  Photo

Media file 3:  Interrupted pledgetted sutures are used to close a ventricular septal defect.
	View Full Size Image
Media type:  Photo

Media file 4:  This angiogram shows a catheter in the right ventricle—severe infundibular stenosis.
	View Full Size Image
Media type:  Photo

Media file 5:  This image shows a closed ventricular septal defect and closure of right ventriculotomy with Gore-Tex.
	View Full Size Image
Media type:  Photo

Media file 6:  Gore-Tex is used for complete closure of right ventriculotomy.
	View Full Size Image
Media type:  Photo

REFERENCES

Section 12 of 12

• Authors and Editors
• Introduction
• Indications
• Relevant Anatomy
• Contraindications
• Workup
• Treatment
• Complications
• Outcome and Prognosis
• Future and Controversies
• Multimedia
• References

• Aboulhosn J, Child JS. Management after childhood repair of tetralogy of fallot. Curr Treat Options Cardiovasc Med. Dec 2006;8(6):474-83. [Medline].
• Arciniegas E, Farooki ZQ, Hakimi M, Green EW. Results of two-stage surgical treatment of tetralogy of Fallot. J Thorac Cardiovasc Surg. Jun 1980;79(6):876-83. [Medline].
• Boechat MI, Ratib O, Williams PL, Gomes AS, Child JS, Allada V. Cardiac MR imaging and MR angiography for assessment of complex tetralogy of Fallot and pulmonary atresia. Radiographics. Nov-Dec 2005;25(6):1535-46. [Medline].
• Borow KM, Green LH, Castaneda AR, et al. Left ventricular function after repair of tetralogy of fallot and its relationship to age at surgery. Circulation. Jun 1980;61(6):1150-8. [Medline].
• Devore GR, Polanko B. Tomographic ultrasound imaging of the fetal heart: a new technique for identifying normal and abnormal cardiac anatomy. J Ultrasound Med. Dec 2005;24(12):1685-96. [Medline].
• Gustafson RA, Murray GF, Warden HE, et al. Early primary repair of tetralogy of Fallot. Ann Thorac Surg. Mar 1988;45(3):235-41. [Medline].
• Horer J, Friebe J, Schreiber C. Correction of tetralogy of Fallot and of pulmonary atresia with ventricular septal defect in adults. Ann Thorac Surg. 2005;80:2285-2291. [Medline].
• Kirklin JW, Blackstone EH, Kirklin JK, Pacifico AD, Aramendi J, Bargeron LM Jr. Surgical results and protocols in the spectrum of tetralogy of Fallot. Ann Surg. Sep 1983;198(3):251-65. [Medline].
• Lee CN, Su YN, Cheng WF, Lin MT, Wang JK, Wu MH. Association of the C677T methylenetetrahydrofolate reductase mutation with congenital heart diseases. Acta Obstet Gynecol Scand. Dec 2005;84(12):1134-40. [Medline].
• Lukacs L, Kassai I, Arvay A. Total correction of tetralogy of Fallot in adolescents and adults. Thorac Cardiovasc Surg. Oct 1992;40(5):261-5. [Medline].
• Pacifico AD, Kirklin JK, Colvin EV, et al. Transatrial-transpulmonary repair of tetralogy of Fallot. Semin Thorac Cardiovasc Surg. Jan 1990;2(1):76-82. [Medline].
• Pacifico AD, Ricchi A, Bargeron LM Jr, et al. Corrective repair of complete atrioventricular canal defects and major associated cardiac anomalies. Ann Thorac Surg. Dec 1988;46(6):645-51. [Medline].
• Patel CR, Agamanolis DP, Stewart JW. Prenatal diagnosis of tetralogy of Fallot with obstructed supracardiac totally anomalous pulmonary venous connection. Cardiol Young. Dec 2005;15(6):656-9. [Medline].
• Sakamoto T, Nagase Y, Hasegawa H, Shin'oka T, Tomimatsu H, Kurosawa H. One-stage intracardiac repair in combination with external stenting of the trachea and right bronchus for tetralogy of Fallot with an absent pulmonary valve and tracheobronchomalacia. J Thorac Cardiovasc Surg. Dec 2005;130(6):1717-8. [Medline].
• Sousa Uva M, Lacour-Gayet F, Komiya T, et al. Surgery for tetralogy of Fallot at less than six months of age. J Thorac Cardiovasc Surg. May 1994;107(5):1291-300. [Medline].
• Touati GD, Vouhe PR, Amodeo A, et al. Primary repair of tetralogy of Fallot in infancy. J Thorac Cardiovasc Surg. Mar 1990;99(3):396-402; discussion 402-3. [Medline].
• Turley K, Tucker WY, Ebert PA. The changing role of palliative procedures in the treatment of infants with congenital heart disease. J Thorac Cardiovasc Surg. Feb 1980;79(2):194-201. [Medline].
• Ungerleider RM. Tetralogy of fallot. In: Sabiston DC, Spencer F, eds. Surgery of the Chest. 6^th ed. Philadelphia, Pa: WB Saunders Co; 1995.
• Redington AN. Determinants and assessment of pulmonary regurgitation in tetralogy of Fallot: practice and pitfalls. Cardiol Clin. Nov 2006;24(4):631-9, vii. [Medline].

Article Last Updated: May 1, 2008